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H2S Electrode Materials and Methods. Phosphate buffered saline (PBS) tablets (1X,
CalBioChem) and cetyl trimethylammonium bromide (CTAB) were used to make buffered solutions (PBS, 140 mM NaCl, 3 mM KCl, 10 mM phosphate, 1 mM CTAB, pH 7.4) in Millipore water. Buffer solutions were sparged with N2 to remove dissolved oxygen and stored in an N2-filled glovebox. Carbonic anhydrase (CA) from bovine erythrocytes (3,500 W/A units/mg) was obtained from Sigma Aldrich and a 1% CA stock solution was prepared in deoxygenated buffer (50 mM PIPES, 100 mM KCl, pH 7.4) in a glovebox, and the absorbance at 280 nm (1 cm path length cuvette) at 37 C was measured to be 3.825. The concentration of the stock solution was calculated to be 67 µM using 280 1% = 19 for CA. 5 The stock solution was stored under nitrogen at 4 C and warmed to room temperature immediately before use. Stock solutions of tris (2-carboxyethyl) phosphine (TCEP) and acetazolamide (AAA) were prepared under N2 with degassed buffer (PBS, pH 7.4) immediately prior to use. Thiocarbamate and carbamate stock solutions were prepared in an N2-filled glovebox in DMSO and stored at -25 C until immediately before use.
General Procedure for H2S Electrode Experiments. Scintillation vials containing 20.00 mL of phosphate buffer (140 mM NaCl, 3 mM KCl, 10 mM phosphate, 1 mM CTAB, pH 7.4) were prepared in an N2-filled glovebox. A split-top septum cap was placed on the vial after probe insertion and the headspace was sparged with N2. The WPI electrode was then inserted into the vial and the measured current was allowed to equilibrate before starting the experiment. With moderate stirring, the CA stock solution (50 µL, 67 µM) was injected, followed by subsequent injections of acetazolamide (10-50 µL of a 10 mM stock solution in PBS buffer), COS gas (10 µL, 0.345 µmol), TCA stock solution (10 mM in DMSO), or TCEP stock solution (10 mM in PBS buffer).
General Procedure for Fluorescence Measurements.
In an N2-filled glovebox, a septumsealed cuvette was charged with 3.00 mL of buffer (140 mM NaCl, 3 mM KCl, 10 mM phosphate, 1 mM CTAB, pH 7.4). The cuvette was removed from the glovebox and MeRho-TCA (60 µL of a 1 mM stock solution) was injected into the vial, after which a background S4 spectrum was recorded. The desired analytes were then introduced, and the fluorescence spectrum was measured at designated time points. Once mixed with either compound 3 or 4, half of each sample was treated with 10 mM TCEP (tris(2-carboxyethyl)phosphine hydrochloride) for 30 minutes while the other half remained untreated. Sulfide bioavailability was subsequently measured in all samples using the MBB method as previously reported.
General
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General procedure for the preparation of thiocarbamates. Sodium hydride (60% in oil, 1.25 mmol) was added to a solution of the isothiocyanate (1 mmol) and the benzyl alcohol (1 mmol) in anhydrous THF (6-12 mL). The reaction mixture was stirred at room temperature under nitrogen for 18 hours. After the solvent was removed under reduced pressure, CH2Cl2 was added, and the resulting solution was washed with water and brine. The organic layer was dried over sodium sulfate and filtered. The solvent was removed by rotary evaporation and the crude product was purified using either column chromatography (hexanes:EtOAc gradient) or silica gel preparatory thin layer chromatography (3:2 hexanes:EtOAc). 
O-(4-Azidobenzyl)-N-(4-fluorophenyl)thiocarbamate (1
O-(4-Benzyl)-N-tolylthiocarbamate (3). Purification via column chromatography
(hexanes/EtOAc gradient) yielded the product as a pure white solid (173.7 mg, 68% 
